Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aulos Bioscience, Inc.
University of Pittsburgh
BicycleTx Limited
Toray Industries, Inc
Jules Bordet Institute
Bristol-Myers Squibb